Clinico-biological Data Collection Study of Metastatic Lung Cancer

RATIONALE : Currently, the mechanisms associated with the response or resistance to treatment are poorly understood and are multifactorial. These mechanisms involve clinical and biological factors associated with the host and the tumor and possibly the patient's psycho-social environment. PURPOSE : This trial will assess the use of a prospective database dedicated to patients with breast cancers that contains clinical data as well as epidemiological, psychological, emotional, social, imaging, biological and biopathological data. These data will allow a creation of new modelling algorithms in

Trial Details

NCT ID
NCT04944030
Phase
NA
Sponsor
Institut Cancerologie de l'Ouest
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Metastasis biopsy
Locations (sample)
  • Angers, France|47.47156,-0.55202
  • Saint-Herblain, France|47.21154,-1.651

Key Eligibility Criteria

  • Written informed consent obtained from the patient prior to performing any protocol-related procedures, including screening biopsy, blood sample an…
  • 18 years old at time of written consent
  • Patient with histologically confirmed lung cancer
  • Lung cancer metastatic disease or locally advanced not eligible for local curative treatment intent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →